Related Experiment Video

Updated: Jun 16, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal

Jeanette Nilsson1, Khalil Helou, Anikó Kovács

  • 1Department of Cell and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.

Cancer Research
|February 11, 2010
PubMed

Insights

Nuclear factor 1-C2 (NF1-C2) loss promotes breast cancer metastasis. Its counterpart, Forkhead box F1 (FoxF1), drives tumor invasion and spread, impacting patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer metastasis is a leading cause of mortality.
  • Understanding the molecular mechanisms driving tumor cell spread is crucial.
  • Epithelial-to-mesenchymal transition (EMT) is a key process in metastasis.

Purpose of the Study:

  • To identify novel molecular pathways regulating breast cancer metastasis.
  • To investigate the roles of nuclear factor 1-C2 (NF1-C2) and Forkhead box F1 (FoxF1) in breast cancer progression.
  • To elucidate the relationship between NF1-C2, FoxF1, and EMT.

Main Methods:

  • Analysis of NF1-C2 and FoxF1 expression in breast tumors and metastases.
  • In vitro manipulation of NF1-C2 and FoxF1 levels using expression and knockdown techniques.
  • Assessment of cellular phenotypes including EMT, motility, and invasiveness.
  • In vivo studies using breast carcinoma xenografts in mice.

Main Results:

  • NF1-C2 is downregulated during tumor progression and absent in metastases; its loss correlates with poorer patient survival.
  • NF1-C2 expression suppresses EMT, motility, invasiveness, and tumor growth.
  • FoxF1 is a direct target of NF1-C2 and its overexpression promotes a mesenchymal phenotype, increased invasiveness, and enhanced tumor growth.
  • FoxF1 expression correlates with mesenchymal phenotypes in breast cancer cells, suggesting a pro-metastatic role.

Conclusions:

  • NF1-C2 acts as a tumor suppressor by inhibiting EMT and metastasis in breast cancer.
  • FoxF1 functions as an oncogene, promoting invasion and metastasis in breast cancer.
  • The NF1-C2/FoxF1 axis represents a novel regulatory pathway with significant implications for breast cancer progression and therapeutic targeting.

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.